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Abstract
Antibiotic resistance forms a serious threat to the health of hospitalised patients, rendering otherwise treatable bacterial
infections potentially life-threatening. A thorough understanding of the mechanisms by which resistance spreads between
patients in different hospitals is required in order to design effective control strategies. We measured the differences
between bacterial populations of 52 hospitals in the United Kingdom and Ireland, using whole-genome sequences from
1085 MRSA clonal complex 22 isolates collected between 1998 and 2012. The genetic differences between bacterial
populations were compared with the number of patients transferred between hospitals and their regional structure. The
MRSA populations within single hospitals, regions and countries were genetically distinct from the rest of the bacterial
population at each of these levels. Hospitals from the same patient referral regions showed more similar MRSA
populations, as did hospitals sharing many patients. Furthermore, the bacterial populations from different time-periods
within the same hospital were generally more similar to each other than contemporaneous bacterial populations from
different hospitals. We conclude that, while a large part of the dispersal and expansion of MRSA takes place among
patients seeking care in single hospitals, inter-hospital spread of resistant bacteria is by no means a rare occurrence.
Hospitals are exposed to constant introductions of MRSA on a number of levels: (1) most MRSA is received from
hospitals that directly transfer large numbers of patients, while (2) fewer introductions happen between regions or (3)
across national borders, reflecting lower numbers of transferred patients. A joint coordinated control effort between
hospitals, is therefore paramount for the national control of MRSA, antibiotic-resistant bacteria and other hospital-
associated pathogens.
DATA SUMMARY
A full list of accession numbers for the whole-genome
sequence data used in this study, as well as the contact
matrix describing the numbers of shared patients between
hospitals, are available as Supplementary Material.
INTRODUCTION
The increase in antibiotic resistance represents a global
threat to public health in general, and to the health
of hospitalised patients in particular. Hospitalised
patients are more susceptible to infections, often with
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opportunistic bacteria that are otherwise harmless com-
mensals. Such infections are usually treatable with antibi-
otics and pose no serious threat to health, but increasing
rates of resistance can make these infections potentially
life-threatening. Curbing the spread of resistance includes
the more prudent use of available antibiotics to reduce the
selective pressure on bacterial populations [1–3] and
implementation of effective control strategies to prevent
the spread of multidrug-resistant strains to unaffected
patient populations. In order to design control strategies,
a thorough understanding of the mechanisms by which
resistance spreads between patients and bacterial popula-
tions in different hospitals is required.
One of the most likely modes of transmission between hos-
pitals is via inter-hospital transfer of colonised patients [4];
each transferred patient offers an opportunity for resistant
bacteria to be exchanged from one hospital to the next. The
overall population of transferred patients creates connectiv-
ity between all health care institutions to form a single
health care network [5–7], through which resistant bacteria
may spread. The structure of this network influences the
spread of resistance, with faster spread towards the tertiary
care institutions and within closely connected regions, and
slower dispersal between hospitals in other regions [8].
Most evidence for inter-hospital spread of resistant bacteria
is anecdotal, based on observed cases that signified the index
case of a hospital outbreak [9, 10]. Although the identifica-
tion of these introductions is important, such evidence has
rarely been considered within the broader context of sus-
tained transmission between hospitals by transferred
patients on a national level.
Methicillin-resistant Staphylococcus aureus (MRSA) is often
used as a model organism to study the spread of drug-
resistant bacteria, owing both its public health importance
and favourable aspects of its population biology that make it
possible to track individual clones over time and space [11,
12]. Low rates of recombination help to maintain relatively
stable patterns of spatio-temporal variation [13]. In the
United Kingdom, two predominant MRSA clones, EMRSA-
15 [Clonal Complex (CC) 22] and EMRSA-16 (CC 30),
have successfully spread through hospitals since the early
1990s [14], with the latter known to have first emerged in
the English midlands in the mid-1980s [15]. The resulting
nationwide epidemic of MRSA infections in the 1990’s
prompted the introduction of a raft of control policies in the
UK, including mandatory surveillance of MRSA bacterae-
mia [16]. Over the past decade MRSA bacteraemia rates
have dropped substantially [16–18], apparently indicating
that MRSA bacteraemias can be prevented by improved
infection control practices in individual hospitals. However,
it is still unclear how these epidemic MRSA clones were able
to spread to all UK hospitals over such a short period and
what forces attenuated their epidemic behaviour.
A number of studies have shed light on the local pro-
cesses underlying the dispersal of MRSA, in particular
between neighbouring hospitals. These showed that
hospitals that exchanged large numbers of patients also
harboured MRSA populations with similar spa types [19]
and an increased proportion of genetically nearly identical
isolates within a single clonal complex [20], indicating an
effect of patient transfers on genetic population structure
of MRSA. However, the structure of the patient referral
networks extends further than the direct connections
between neighbouring hospitals, and these higher levels of
organisation will inevitably affect the dispersal of MRSA
and other antibiotic-resistant bacteria. Moreover, these
studies were based on the community-acquired clone
USA300 (ST8), which confers a significant public health
burden in North America. This clone is not restricted to
health-care settings, and therefore is likely to exhibit epi-
demiological properties that are quite distinct from those
of the two hospital-adapted clones, EMRSA-15 and
EMRSA-16, common in the UK.
In order to obtain a comprehensive view of how the patient
referral network affects the dispersal of antibiotic-resistant
bacteria, we studied a single MRSA clonal complex, CC22,
isolated in hospitals in the United Kingdom and the Repub-
lic of Ireland (UK and I). Using whole-genome sequencing,
we compared the genetic composition of hospital MRSA
populations to determine their relatedness at the highest
resolution possible and ascertained the effect of the struc-
ture of the patient referral network on the spread of MRSA.
Whilst an overview of the genetic structuring of EMRSA-15
in the UK has previously been reported [21] that study
focussed more on contextualising local outbreaks than on
addressing the role of patient referral in inter-hospital
transmission.
IMPACT STATEMENT
To curb the spread of antibiotic resistance in health care,
the spread of resistance between hospitals needs to be
understood. Here we test the extent to which patient
referrals influence the frequency of inter-hospital trans-
mission. We used whole-genome sequencing to compare
methicillin-resistant Staphylococcus aureus isolated from
patients in hospitals across the UK and Ireland, allowing
the comparison of bacterial populations in hospitals with
a higher resolution than traditional typing methods. The
genetic population structure mirrored the hierarchical
structure of the patient referral network, with distinct
bacterial populations at each level, from hospitals to
regions to countries, confirming a key role of patient
referral in the spread of resistant bacteria among hospi-
tals. Coordinated control efforts between hospitals within
the same regions are thus vital to mitigate the spread of
MRSA and other antibiotic-resistant hospital-associated
pathogens between hospitals, because most introduc-
tions into a given hospital originate from hospitals that
directly transfer large numbers of patients.
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METHODS
Isolate collection
We collected 783 MRSA clonal complex (CC) 22 isolates
between 2001 and 2010 from 45 hospitals across the UK
and I through the British Society of Antimicrobial Chemo-
therapy (BSAC) bacteraemia resistance surveillance pro-
gramme [22, 23]. Additional MRSA CC22 bacteraemia
isolates were retrospectively collected from nine hospitals in
the East of England between 1998 and 2012. One hospital
contributed to both the BSAC collection and the East of
England collection, and only non-duplicate isolates were
included in the analysis. Hospital names were coded by let-
ters according to their region, to preserve anonymity.
DNA was extracted for each MRSA isolate using a QIAx-
tractor (QIAGEN), and was prepared for sequencing with
the use of a Nextera DNA Sample Preparation Kit (Epicen-
ter). Index-tagged libraries were created, and 96 separated
libraries were sequenced in each of eight channels using the
HiSeq platform (Illumina) to generate 100 base pair (bp)
paired-end reads. All sequences were submitted to the Euro-
pean Nucleotide Archive (ENA), and individual accession
numbers are given in Table S1 (available in the online Sup-
plementary Material). Sequence reads were mapped to refer-
ence genome HO 5096 0412 [10, 15] (GenBank reference
number HE681097.1) using SMALT v0.7.4 [24] to identify
single-nucleotide polymorphisms (SNPs). SNPs were fil-
tered to remove those at sites with a SNP quality score
below 30, and SNPs at sites with heterogeneous mappings
were filtered out if the SNP was present in less than 75% of
reads at that site. Mobile genetic elements, phage and repeti-
tive regions were excluded from the alignment, leaving a
core genome size of 2 655 809 bp (A full list of excluded
regions is available in Table S2). Phylogenetic trees were
reconstructed using RaxML with the general time reversal
model and gamma correction [25]. Twenty sequences
belonging to sporadic community-acquired MRSA (with an
SCCmec type other than type IVh) which are more diverse
and do not belong to the EMRSA-15 linage were excluded
from the analysis, leaving 1085 sequences.
Patient referral network
We used data from the NHS Hospital Episode Statistics to
reconstruct the patient referral network. Data about hospital
admissions between April 2006 and March 2009 were ana-
lysed at patient level. The time frame for patient admission
data was restricted to three years to limit the influence of
changes in the health care system, such as mergers of hospi-
tals. We thus assume that the observed three-year-based
network is representative for the majority of patient move-
ments spanning the sampling interval of the strain collec-
tion. For all patients, all consecutive admissions Aij to
hospital i after a previous admission to hospital j were
counted. This included both referrals that were direct from
one hospital to another as well as indirect, after a stay at
home. All patient readmissions were combined mij=
P
Aij in
one matrix M={mij}, which defines the weight of
connectedness between any two hospitals based on the
number of patients that they shared. We used a community
assignment algorithm maximising modularity Q [26] to
assign health care regions in the patient referral network, as
described previously [5].
Genetic population structure
In order to estimate the genetic flow between bacterial pop-
ulations, we utilised an adapted version of the Wright’s F
statistic. We treated every nucleotide position as a separate
gene, with the four nucleotides of the genetic code as the
total number of possible alleles. For each position i, we cal-
culated the percentage of each nucleotide in the sequences
from the population j in question, pjix=Njix/Nj, x={A,T,C,G},
where Nj denotes the number of sequences from population
j and Njix denotes the number of sequences with nucleotide
x at position i.
The mean number of SNP differences between the sequen-
ces of a single population is a poor measure of the variation
within the population when the number of single occurring
SNPs (singletons) is relatively high. In our data 19 785 out
of 26 337 SNP positions (75%) were singletons. We there-
fore calculated for each nucleotide position the chance of
picking two sequences from both populations, forming the
same heterozygous pair. The underlying idea is that any
SNP that is not completely present or absent from both
populations can be informative about the exchange of bac-
teria between these populations. If we assume that each SNP
only arises once, a SNP partially present in two populations
is the result of an introduction into one or both of the
populations.
Only a small number of nucleotide positions [22 (0.3 %),
excluding the singletons] contained more than two variants
and given each SNP location i the sum over the probabilities
of picking two heterozygous SNP pairs (one pair from pop-
ulation 1, with proportion p1i, and one pair from popula-
tion 2, with proportion p2i) can therefore be written as
Hp ¼
X
i
p1i 1  p1ið Þ p2i 1  p2ið Þ;
denoting the between-population variation. Within each of
the populations, the sum over the probabilities of picking
two identical heterozygous pairs then defines HSj=Si (pji
(1-pji))
2 and the mean over the two populations HS=(HS1
+HS2)/2 then denotes the within-population variation. Our
FSP is then calculated as
Fsp ¼ ðHs  HpÞ=Hs ¼ 1 HP=HS;
which ranges between 0 (HP=HS) and 1 (HP=0).
In order to calculate the divergence of a single population,
h, we calculated FST in the same way as FSP, except we
assumed the rest of the populations to be one single joined
population. This is done by taking the mean over all SNP
frequencies for the other populations, p2ix=Sk 6¼hpkix/(Nk
 1), where Nk is the number of populations.
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Population differences
Isolates were grouped into populations by hospital, and any
population with fewer than five isolates was excluded. To
allow the ascertainment of temporal differences in bacterial
populations, we split each hospital’s population into time
periods of three years (1998–2000, 2001–2003, 2004–2006,
and 2007–2009, and 2010–2012) in a parallel analysis, again
excluding all populations with fewer than five isolates. For
regions and countries, we assumed SNP frequencies per
hospital were representative for the populations and calcu-
lated the SNP frequencies for each population at these levels
as the mean SNP frequencies over the included hospitals.
To test if the measured divergence of populations deviated
from what could be expected at random given the structure
of our data, we performed permutation tests based on differ-
ent levels of isolate grouping. In the first permutations, we
randomised all isolates, keeping the number of isolates per
hospital equal to the original dataset. In the parallel permu-
tation, we randomised the hospitals, keeping their number
per region and country constant. For each level we created
1000 permutations and calculated FST for all populations in
each dataset.
We calculated the FSP for each pair of regions and compared
these with random permutations of all hospitals in both
regions disregarding the original geographical partition.
These permutations were repeated 1000 times. Furthermore,
we calculated FSP between all possible pairs of hospital-time
frames for which more than five isolates were available.
In order to test the effect of inter-connectedness between
hospitals within each health care region on the bacterial
genetic population structure, the data from all hospitals in
each region containing three or more hospitals were com-
bined. When combining the data from multiple hospitals,
for instance into regions, we assumed that the samples from
one hospital are representative for the entire MRSA popula-
tion of that hospital, and took the mean of the SNP propor-
tions of the hospitals as the proportions for the combined
set, pRix=
P
j2rpjix/NR, where NR denotes the number of hos-
pitals in region R.
Travel time between hospitals
The geographical position of the hospitals was determined
using their postcodes, and distances between all hospitals
was measured as the travel time by car, in absence of traffic,
between the geo-locations using the Open Source Routing
Machine, based on the OpenStreetMap database (http://
project-osrm.org).
Possible introductions
To identify introduction events, we selected sub-clades with
five or more isolates from the phylogeny. We consider a
possible introduction (PI) to be represented by an isolate
assigned to an otherwise geographically homogeneous clade
(all isolates from the same hospital) that was isolated from a
patient in another hospital. Monophyletic isolates from the
same destination hospital were counted as a single PI. We
took a conservative approach and only assigned PIs where
the putative donor hospital was represented by at least four
isolates and contributed at least 80% of the isolates within
the clade.
RESULTS
The total collection comprised 1085 CC22 isolates, of which
1074 isolates were EMRSA-15 (ST22), originating from 52
hospitals across the United Kingdom and the Republic of
Ireland (henceforth UK and I, Fig. 1a). Thirty-three hospi-
tals submitted five or more isolates. Two hospitals in region
East-2 (Hospital C and Hospital D) were over-represented
in our dataset due to in-depth sampling, with 157 and 166
isolates, respectively. Hospitals in England were divided
according to 12 ‘referral regions’ based on the structure of
the patient movements between all hospitals (Table S3) as
previously described [21, 27]. Three regions included three
hospitals with five or more isolates (East-1, East-2 and West
Midlands), and one region lacked any hospital with enough
isolates (North-East 2).
The phylogeny based on the 1085 whole-genome sequences
showed clear regional clustering (Fig. 2a), exemplified by
the large clusters from Northern Ireland (note the cluster at
the bottom of the tree in Fig. 2a). Isolates from single hospi-
tals also clustered, which was particularly apparent for the
over-represented hospitals in region East-2. In contrast little
or no temporal clustering was evident, thus bacterial popu-
lations within a single region seem to remain relatively sta-
ble over time.
In order to quantify the genetic similarity between bacterial
populations we used Wright’s F-statistic, which is a stan-
dard population genetics metric commonly used to estimate
the degree of gene flow, where a value of 0 indicates that
populations are identical, and a value of 1 indicates that
populations are completely isolated from each other. We
first calculated the mean FST, comparing single populations
with the entire combined population, over the different lev-
els of the health care system: hospitals, referral regions (as
defined by the structure of the patient referral network),
and countries. The mean FST for each level was higher than
would be expected if isolates were distributed randomly
(Fig. 2b), indicating that isolates within the bacterial popu-
lations at each level were generally more related to each
other than those in other bacterial populations at that level.
When randomising the bacterial populations of hospitals,
instead of single isolates, over the available hospital loca-
tions, we found that the mean FST for regions and countries
was also higher compared with the permutations randomis-
ing hospital locations.
The original partitioning of hospitals in referral regions fit-
ted better (i.e. maximised the pair-wise F-statistic, FSP,
between regions) than most of the random partitions
(Fig. 3a, b). Even for East-1 and East-2, the only referral
regions in this analysis with a border and with three or
more hospitals in the dataset, the bacterial populations dif-
fered significantly from the random partitions, despite the
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geographical proximity. In only two instances did a random
partitioning at the country level result in a higher FSP. Both
involved a partitioning between Scotland and Northern Ire-
land that included hospitals A, E and G in Scotland (all in
the West of Scotland) and either hospital Scotland-D (FSP
=0.780) or hospital Scotland-B (0.723) being included with
the hospitals in Northern Ireland, instead of with the rest of
Scotland (0.714). Otherwise health care regions defined on
the basis of the observed patient referral between hospitals
were the best way to divide the bacterial populations of all
hospitals.
The genetic differences between pairs of bacterial populations
show the clear hierarchical structure of the MRSA population
in the UK and I (Fig. 3c). Bacterial populations within each
hospital were genetically most similar, followed by those
within each region, and finally those within each country
(Fig. 3d). This was also observed when comparing the bacte-
rial populations of hospitals irrespective of the time of isola-
tion. Bacterial populations from the same time period from
different hospitals as equally divergent as any randomly cho-
sen combination of populations, indicating that the MRSA
populations within hospitals are largely conserved over time.
Number of isolates Ireland
Northern Ireland
Scotland
Wales
South East
South West
South Central
West Midlands
North West 1
East 2
Central-East Midlands
North Central
North East 1
North West 2
North East 2
East 1
1
5
20
50
100
200
Fig. 1. Overview of hospitals, health care regions and MRSA samples. The map of the United Kingdom and Ireland, coloured by refer-
ral cluster, depicting Wales, Scotland, Northern Ireland, and the Republic of Ireland indicated as single referral clusters. Each circle
represents a hospital, identified by a letter unique to the region, on an arbitrary place in the region. Circle sizes represent the number
of isolates included per hospital.
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Hospitals that shared more patients generally showed genet-
ically more similar bacterial populations (Fig. 4a, Mantel
test P<0.001). This was particularly apparent for hospitals
that exchanged more than 100 patients per year, after which
FSP values dropped considerably. Hospitals with larger sam-
ple sizes showed a consistent dependency on patient
exchanges whereas those with fewer isolates showed a larger
variability in FSP. However, the effect of patient exchanges
could not be directly distinguished from the effect of geo-
graphical distance between hospitals (measured in travel
time, Fig. 4b, Mantel test P<0.001), owing to the strong cor-
relation between the two (Fig. 4c, Mantel test P<0.001).
Among all isolates, we identified 30 that mapped to a clade
occupied by a majority from another single hospital. These
isolates thus show the hallmarks for introductions from one
hospital to another. Although this introduction could have
happened indirectly, through an intermediate health care
institution, the donor hospital’s bacterial population was the
most likely source. Many of these introductions occurred at
relatively short distances, yet a small number of introduc-
tions occurred over considerable distances (Fig. 5).
DISCUSSION
By sequencing a large, representative collection of the most
prevalent MRSA clonal complex throughout the UK and
the Republic of Ireland, we were able to give a comprehen-
sive description of its population structure, and propose its
most likely dispersal dynamics. Our results indicate that the
spread of MRSA is governed by a hierarchy of processes act-
ing simultaneously on multiple levels – within single hospi-
tals, between hospitals within health care regions, between
regions within a country and between countries, that reflect
the structure of patient movements throughout the health
care system. The identification of patient movements as a
potential transmission pathway is important to the design
of effective control strategies to reduce the transmission of
MRSA and other antibiotic-resistant micro-organisms
between patients and hospitals.
The analysis provides clues as to the most apposite geo-
graphical and temporal scales with which to describe the
distribution of MRSA variants. A large proportion of the
expansion of MRSA took place within single hospitals,
resulting in the population of given hospital in a given year
being more similar to the population of the same hospital in
other years than to those of other contemporaneous hospital
populations. This indicates that the population of MRSA
circulating within each hospital is stable over time, and is
not frequently perturbed by introductions from other hospi-
tals. It does not necessarily mean, however, that there was a
continuous transmission within the hospital at all times,
and the role of community reservoirs within the hospital
catchment area also needs to be considered. Patients who
were MRSA-colonised during one hospital stay might
reintroduce the organism during subsequent stays. The
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observation that sustained MRSA populations exist in single
hospitals does, however, justify continued emphasis on
strong infection control within hospitals.
The bacterial populations within hospitals are not
completely isolated, as the association between bacterial
populations extends from the same hospital to hospitals in
the same health care region, apparent as a coherent regional
genetic population structure. There were only two instances
where a random partition of hospitals provided a better fit
of the observed genetic diversity than the geographical divi-
sion. Both cases concerned hospitals in Scotland and North-
ern Ireland, areas in which the true patient referral pattern
was not included. It is likely that hospitals in the East and
West of Scotland should be treated as different health care
regions based on patient movements [28, 29], and not be
assigned arbitrarily as single entity along administrative
borders as was done in the present analysis.
Bacterial populations of different countries are largely segre-
gated, in particular between Ireland (including Northern
Ireland) on the one hand and England, Scotland and Wales
on the other. This country-specific clustering is likely to
reflect the observation that patients are less likely to travel
across national borders to seek healthcare unless there is a
very good reason to do so. Furthermore, this finding is con-
sistent with previously observed country-specific clades in
the MRSA ST-22 population structure [15] and the cluster-
ing of different clonal complexes observed in other Euro-
pean countries [13]. The reduced flow of patients across
countries’ borders thus seems to mitigate the international
dispersal of MRSA and other health care-associated infec-
tions. This should be taken into account when considering
the likely increase in patients seeking health care across bor-
ders, facilitated by changes in policy (such as EU directive
2011/24/EU, that stipulates the right of EU citizens to seek
health care in other EU countries).
Our findings confirm that hospitals that exchange many
patients had genetically more similar bacterial populations
than hospitals further afield, as found by other studies [19,
20]. This process is likely to be driven by the exchange of
MRSA colonised or infected patients between hospitals.
However, we could not distinguish spread through the gen-
eral human population from spread through hospitals by
transferred patients. This is caused by the strong geographi-
cal component in patient transfers, as patients and doctors
are likely to choose the closest hospital that offers the
required treatment. However, dispersal through patient
movements seems more likely, given the agreement between
the division of the patient referral network in referral
regions and the genetic population structure of MRSA in
the hospitals. Irrespective of the exact mode of transmission
between hospitals, the proximity of hospitals influences the
chances of inter-institutional dispersal. Control strategies
should take this inter-hospital dispersal into account, for
instance through regional coordination of infection preven-
tion and control efforts, as the failure of control in one
hospital will impinge on its surrounding health care institu-
tions [30, 31].
We were also able to describe a limited number of possible
introductions of MRSA over medium- and long-range dis-
tances. Although the underlying process for these introduc-
tions remains elusive, and the international transfer, and
subsequent establishment, of MRSA appear to be relatively
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rare events [32, 33], it does illustrate that regions and coun-
tries are not completely isolated entities and experience a
constant pressure of introduction. One possible explanation
for these introductions is the necessity for patients to travel
for highly specialised treatments (e.g. transplantation),
bringing with them a strain prevalent in their home hospital
to the far away hospital or vice versa. However, these long-
distance exchanges may also have other causes, such as the
movement of health care workers, or patients’ personal resi-
dential choices.
Limitations
We acknowledge several limitations of our study. First, our
sample was largely based on the isolates collected for the
BSAC Bacteraemia Resistance Surveillance Programme [22,
23], and as such includes only a proportion of all hospitals
in the UK and the Republic of Ireland and a small propor-
tion of all MRSA-positive samples within each hospital.
Among the included hospitals, some submitted very few
MRSA isolates, and as such were excluded from part of the
analysis. The unobserved hospitals’ bacterial populations
may have influenced some of the results. In particular, some
of the included isolates may have been imported from unac-
counted hospitals, linking hospitals through unobserved
bacterial populations. Furthermore, this sampling scheme
greatly reduces the number of hospital pairs in the network
that exchange a high number of patients (>1000 patients/
year), making the identification of mixed bacterial popula-
tions more difficult.
To make sure that we observed hospital pairs that
exchanged a high number of patients, we included isolates
from hospitals in the east of England. This resulted in both
a higher number of hospitals, as well as a higher number of
isolates, from region East-2 in particular. This oversampling
may have resulted in more possible introductions being
identified to and from this region but is unlikely to make a
large difference for the other results and final conclusions.
To test if the genetic composition of the hospital MRSA
populations were consistent with the regional structure of
the patient referral network, we used a permutation test that
was restricted to the original size partitioning of the regions.
It did not test all possible divisions of the available hospitals,
which is next to impossible given the large number of possi-
ble partitions. However, by using this pair-wise approach
we expect to have tested the most meaningful partitions,
combining hospitals that can be expected to present
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Fig. 5. Possible introductions of MRSA between hospital populations can be inferred from the phylogeny. Arrows show introductions
between hospitals (Indicated by letters per region), from the predominant hospital of the clade to the hospital that submitted the dis-
cordant isolate. While most possible introductions occur within the same region or between neighbouring regions, a number of intro-
ductions span considerable distances.
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genetically similar bacterial populations. Furthermore, we
defined these health care regions using a community assign-
ment algorithm that maximises modularity Q [26]. This
modularity reflects the number of exchanged patients
within regions relative to the exchanges between regions. It
is not guaranteed that this delivers the most meaningful par-
titioning reflecting the dispersal of MRSA. The South-East
and East-1 regions, for instance, exchange 10 times as many
patients between them than two typical other regions, which
may in turn cause more introductions of MRSA between
these regions. Although other methods for finding commu-
nity structure in networks are available [34], the relative
advantages and limitations of these different methods relat-
ing to the population structure of a pathogen spreading
through the network remain unclear.
Lastly, a combined UK patient referral network is difficult
to construct because patient referral data are not directly
comparable between countries. Northern Ireland and the
Republic of Ireland had no patient-level data available, while
coupling the Scottish patient data with the English and
Welsh would probably have led to patients not being linked
during cross-border exchanges, confounding the network.
We therefore used only patient movement data from Eng-
land, and defined the other countries as single health care
regions. As previously discussed this affected the results for
Scotland in particular, emphasising the importance of the
analysis of the patient referral networks. Despite these limi-
tations, however, we were able to disentangle the genetic
population structure of MRSA using the structure of patient
referral patterns.
Conclusions
The control of healthcare-associated infections caused by
antibiotic-resistant organisms is currently the responsibility
of individual hospitals. As a consequence, public health pol-
icy and infection control measures are targeted towards
individual hospitals, rather than the wider healthcare sys-
tem. Our data indicate that there is a high level of temporal
stability of the bacterial population circulating within any
given hospital, suggesting that a large part of the dispersal
and expansion of MRSA takes place among patients seeking
care in single hospitals. However, this individual hospital
approach may only partially be justified, as it does not take
into account the potential influence of other hospitals.
Inter-hospital spread of resistant bacteria is by no means a
rare occurrence; our results show how hospitals are exposed
to constant introductions of MRSA on a number of levels,
from single hospitals, through regions to entire countries.
We propose that patient transfers between hospitals are the
likely process behind the bacterial exchanges, although
spread through the general population, by movement of
health care workers or other mechanisms cannot be ruled
out. This may however depend on the nature of the bacterial
lineages in question, with community-associated strains
relying less on patient transfers. Nevertheless, the hierarchi-
cal nature of the MRSA population structure mirrors the
levels of patient sharing, with most MRSA received from
hospitals that directly transfer large numbers of patients.
Fewer introductions happen between health care regions or
across national borders, reflecting lower numbers of trans-
ferred patients. Even over these long distances, however,
multiple introductions were identified.
Knowledge of the inter-hospital dispersal of MRSA and
other health care-associated pathogens is crucial for the
design of effective control strategies. The exposure to MRSA
between hospitals imposes a shared responsibility for infec-
tion control efforts. Our results indicate that these control
efforts are best coordinated regionally, among groups of
hospitals that share patients. It is worth emphasising that
these regions are determined by the movements of patients
between hospitals, and do not necessarily overlap with the
administrative regions of the health care system. The
absence of a collaborative design of infection control meas-
ures can give the bacteria the opportunity to escape to other
hospitals, undermining control efforts. A joint coordinated
control effort between hospitals, at the very least at a
regional level, is paramount for the national control of
MRSA and other hospital-associated pathogens.
We also demonstrated the usefulness of whole-genome
sequencing (WGS), for determining the relatedness of bac-
terial populations from different hospitals and regions,
where conventional typing methods would have failed. As
WGS becomes more widely available and sequence data-
bases that provide epidemiological information are bound
to grow, our understanding about the dynamics of transmis-
sion and the dispersal of bacteria and the role of reservoirs
will undoubtedly inform better and more targeted interven-
tion strategies. With the incorporation of WGS as part of
the routine diagnostic procedures surveillance systems can
tap into this rich resource.
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